Zymeworks Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
108 PATRIOT DRIVE, SUITE A, MIDDLETOWN, DE, 19709
Mailing Address
108 PATRIOT DRIVE, SUITE A, MIDDLETOWN, DE, 19709
Phone
302-274-8744
Fiscal Year End
1231
EIN
883099146
Financial Overview
FY2025
$124.32M
Total Liabilities
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 3 Initial insider ownership report | April 7, 2026 | View on SEC |
| 4 Insider stock transaction report | April 7, 2026 | View on SEC |
| 8-K Current report of material events | April 1, 2026 | View on SEC |
| 8-K Current report of material events | March 2, 2026 | View on SEC |
| 8-K Current report of material events | March 2, 2026 | View on SEC |
| 10-K Annual financial report | March 2, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 13, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 12, 2026 | View on SEC |
| 3 Initial insider ownership report | February 2, 2026 | View on SEC |
| 4 Insider stock transaction report | January 13, 2026 | View on SEC |
Annual Reports
10-K
March 2, 2026
- Lead candidate zanidatamab advanced to late-stage clinical development with upcoming data readouts expected in late 2024/early 2025.
- Strong strategic collaborations with major pharmaceutical companies (e.g., Jazz, J&J, GSK) provide non-dilutive funding and validate technology platforms.
Material Events
8-K
Leadership Change
April 1, 2026
Medium Impact
- Appointment of Kristin Stafford as CFO signals transition to commercial-stage operations.
- Separation of CEO and CFO roles reduces key-person risk and improves governance.
Insider Trading
STRONG SELL
4 insiders
10 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.